Feed aggregator

Ask an Advisor: Should I Retire? I'm 60, Have $1.1M Cash, $880K in a 401(k), Pensions and Social Security

Top Stories - Mon, 04/20/2026 - 02:00

Petrobras (PBR) Upgraded at BofA Amid Higher Oil Prices

Top Stories - Mon, 04/20/2026 - 01:32

AT&T (T) – Among the 10 Best Affordable Blue Chip Stocks to Buy Now

Top Stories - Mon, 04/20/2026 - 01:32

BP Price Target Lowered by $2 at TD Cowen

Top Stories - Mon, 04/20/2026 - 01:31

Analyst Upgrades Ford Motor (F) to ‘Buy’, Cites Strong Earnings Potential

Top Stories - Mon, 04/20/2026 - 01:31

National Australia Bank flags $503 million impairment hit on Mideast volatility

Top Stories - Sun, 04/19/2026 - 19:48

Travere Therapeutics (TVTX) Climbs 40.8% on Filspari Approval

Top Stories - Sun, 04/19/2026 - 19:47

Mizuho Cuts PT on ADMA Biologics Inc. (ADMA) to $24 From $30

Top Stories - Sun, 04/19/2026 - 19:12

Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29

Top Stories - Sun, 04/19/2026 - 19:12

JonesResearch Initiates Coverage of Relay Therapeutics (RLAY) With a Hold Rating

Top Stories - Sun, 04/19/2026 - 19:12

Canaccord Initiates Coverage of Biohaven Ltd. (BHVN) With a Buy Rating

Top Stories - Sun, 04/19/2026 - 19:11

H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

Top Stories - Sun, 04/19/2026 - 19:11

Why Mesoblast Limited (MESO) is One of the Best Low Priced Biotech Stocks to Invest in

Top Stories - Sun, 04/19/2026 - 19:11

Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?

Top Stories - Sun, 04/19/2026 - 19:11

Ocular Therapeutix (OCUL) Announces Additional Positive Data From the SOL-1 Phase 3 Superiority Trial of AXPAXLI

Top Stories - Sun, 04/19/2026 - 19:10

Guggenheim Cuts PT on Valneva SE (VALN) to $11 From $13

Top Stories - Sun, 04/19/2026 - 19:10

B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14

Top Stories - Sun, 04/19/2026 - 19:09

Cantor Fitzgerald Downgrades ADMA Biologics Inc. (ADMA) to Neutral From Overweight

Top Stories - Sun, 04/19/2026 - 19:09

Is Halozyme Therapeutics (HALO) One of the Most Undervalued Biotech Stocks to Buy Right Now?

Top Stories - Sun, 04/19/2026 - 19:08

RBC Capital Lifts PT on Incyte Corporation (INCY) to $95 From $92

Top Stories - Sun, 04/19/2026 - 19:08
Syndicate content
 
Worldstockexchange® Information Center